FDA approves new pill to reduce pain from endometriosis
TRENTON, N.J. (AP) - U.S. regulators have approved a new treatment for pain caused by endometriosis.
The common condition involves abnormal tissue growth from the uterus that can cause pain and infertility.
Drugmaker Abbvie said Tuesday that the Food and Drug Administration approved its drug, Orilissa, for pain during menstruation and at other times. The company says it's the first new pill for endometriosis in a decade.
In testing, it significantly reduced menstrual pain in about 45 percent of women given a low dose and 75 percent given a high dose, compared to about 20 percent of women given dummy pills.
The drug works by reducing production of the hormone estrogen. That caused side effects in some participants, including hot flashes and bone thinning.
Orilissa will cost $845 every four weeks without insurance.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Holiday Express on schedule to arrive in Gonzales Thursday; road closures announced
Tenants ask apartment management to make significant changes, address mold
Lane shift on I-10 West pushed back to Friday; delayed by cold...
Attorney General elect orders in depth review of State Police
Landry names new head of Louisiana State Police